Xeris Biopharma Holdings (XERS) Gross Margin (QoQ) (2020 - 2026)

Xeris Biopharma Holdings (XERS) Gross Margin (QoQ) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn
10 Xeris Biopharma Holdings 1.07 Bn 954.87 Mn 72.55 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.00
Dec 31, 2025 203.00
Sep 30, 2025 185.00
Jun 30, 2025 -211.00
Mar 31, 2025 125.00
Dec 31, 2024 928.00
Sep 30, 2024 -884.00
Jun 30, 2024 -151.00
Mar 31, 2024 236.00
Dec 31, 2023 -8.00
Sep 30, 2023 291.00
Jun 30, 2023 -385.00
Mar 31, 2023 296.00
Dec 31, 2022 -129.00
Sep 30, 2022 131.00
Jun 30, 2022 941.00
Mar 31, 2022 -560.00
Dec 31, 2021 630.00
Sep 30, 2021 887.00
Jun 30, 2021 -1,570.00